PORCILIS LAWSONIA ID LYOPHILISATE AND SOLVENT FOR EMULSION FOR INJECTION FOR PIGS
PORCILIS LAWSONIA ID LYOPHILISATE AND SOLVENT FOR EMULSION FOR INJECTION FOR PIGS
Authorised
- Water for injection
- Lawsonia intracellularis, strain SPAH-08, Inactivated
Product identification
Medicine name:
PORCILIS LAWSONIA ID LYOPHILISATE AND SOLVENT FOR EMULSION FOR INJECTION FOR PIGS
Porcilis Lawsonia ID, süsteemulsiooni lüofilisaat ja lahusti sigadele
Active substance:
- Water for injection
- Lawsonia intracellularis, strain SPAH-08, Inactivated
Target species:
-
Pig
Route of administration:
-
Intradermal use
Product details
Active substance and strength:
-
Water for injection0.20millilitre(s)1.00Dose
-
Lawsonia intracellularis, strain SPAH-08, Inactivated5323.00unit(s)1.00Dose
Pharmaceutical form:
-
Lyophilisate and solvent for emulsion for injection
Withdrawal period by route of administration:
-
Intradermal use
- Pig
-
All relevant tissues0day
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI09AB18
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Estonia
Package description:
- Cardboard box with 10 x 100 doses of vaccine and cardboard box with 10 x 20 ml solvent
- Cardboard box with 1 x 100 doses of vaccine and cardboard box with 1 x 20 ml solvent
- Cardboard box with 10 x 50 doses of vaccine and cardboard box with 10 x 10 ml solvent
- Cardboard box with 1 x 50 doses of vaccine and cardboard box with 1 x 10 ml solvent
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
- INTERVET INTERNATIONAL B.V.
Responsible authority:
- RAVIMIAMET
Authorisation number:
- 2276
Date of authorisation status change:
Reference member state:
-
France
Procedure number:
- FR/V/0424/001
Concerned member states:
-
Austria
-
Belgium
-
Bulgaria
-
Croatia
-
Cyprus
-
Czechia
-
Denmark
-
Estonia
-
Finland
-
Germany
-
Greece
-
Hungary
-
Iceland
-
Ireland
-
Italy
-
Latvia
-
Lithuania
-
Luxembourg
-
Netherlands
-
Norway
-
Poland
-
Portugal
-
Romania
-
Slovakia
-
Slovenia
-
Spain
-
Sweden
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
Estonian (PDF)
Published on: 14/06/2023
How useful was this page?: